Clinical Trials Directory

Trials / Completed

CompletedNCT04720469

A Second Magnetic Resonance Guided Focused Ultrasound Thalamotomy for Essential Tremor

A Safety Pilot Clinical Trial of a Second Magnetic Resonance Guided Focused Ultrasound (MRgFUS) Thalamotomy for the Management of Medication-refractory Essential Tremor

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Sunnybrook Health Sciences Centre · Academic / Other
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

This study will be a single-centre, prospective, single-arm, open-label, 12-week pilot trial assessing the safety and preliminary efficacy of a second MR-guided focused ultrasound (MRgFUS) thalamotomy on the naïve brain hemisphere after 48 weeks or more of the first MRgFUS thalamotomy in patients with medication-refractory ET. This study will be conducted at the Focused Ultrasound Centre of Excellence at Sunnybrook Health Sciences Centre/University of Toronto.

Detailed description

Patients who are medication-refractory for ET often require a surgical option to relieve symptoms of ET and improve quality of life. To-date, unilateral MRgFUS has been beneficial in providing patients with some of relief from tremor. However, tasks that require two hands remain a challenge for many patients. Historical risks of bilateral treatment have been an impediment to complete tremor relief. The introduction of MRI and current stereotactic methodologies has significantly reduced the probability of non-target tissue injury. In this study, a second MRgFUS thalamotomy will be performed in a cohort of patients who have already successfully undergone unilateral MRgFUS treatment. Tremor severity, speech, balance, gait, and cognition will be assessed during baseline and follow up visits.

Conditions

Interventions

TypeNameDescription
DEVICEMRgFUS thalamotomyAblation of untreated thalamus using focused ultrasound to abate tremor.

Timeline

Start date
2020-10-05
Primary completion
2024-03-18
Completion
2024-03-18
First posted
2021-01-22
Last updated
2024-04-26

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04720469. Inclusion in this directory is not an endorsement.